The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 286K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hata, D.
Right arrow Articles by Kawakami, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hata, D.
Right arrow Articles by Kawakami, T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/4/1235/ $5.00
The Journal of Experimental Medicine, Volume 187, Number 8, April 20, 1998 1235-1247

Articles

Involvement of Bruton's Tyrosine Kinase in Fc{varepsilon}RI-dependent Mast Cell Degranulation and Cytokine Production

Daisuke Hata*, Yuko Kawakami*, Naoki Inagaki{ddagger}, Chris S. Lantz§, Toshio Kitamura||, Wasif N. Khan, Mari Maeda-Yamamoto*, Toru Miura*, Wei Han*, Stephen E. Hartman*, Libo Yao*, Hiroichi Nagai{ddagger}, Anne E. Goldfeld**, Frederick W. Alt, Stephen J. Galli§, Owen N. Witte{dagger}{dagger}, and Toshiaki Kawakami*

From the * Division of Allergy, La Jolla Institute for Allergy and Immunology, San Diego, California 92121; the {ddagger} Department of Pharmacology, Gifu Pharmaceutical University, 5-6-1 Mitahorahigashi, Gifu 502, Japan; the § Departments of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115; the || Department of Hematopoietic Factors, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108, Japan; the Howard Hughes Medical Institute, Children's Hospital, Enders 861, Boston, Massachusetts 02115; the ** Dana-Farber Cancer Institute, Boston, Massachusetts 02115; and the {dagger}{dagger} Howard Hughes Medical Institute, University of California, Los Angeles, California 90024-1662

We investigated the role of Bruton's tyrosine kinase (Btk) in Fc{varepsilon}RI-dependent activation of mouse mast cells, using xid and btk null mutant mice. Unlike B cell development, mast cell development is apparently normal in these btk mutant mice. However, mast cells derived from these mice exhibited significant abnormalities in Fc{varepsilon}RI-dependent function. xid mice primed with anti-dinitrophenyl monoclonal IgE antibody exhibited mildly diminished early-phase and severely blunted late-phase anaphylactic reactions in response to antigen challenge in vivo. Consistent with this finding, cultured mast cells derived from the bone marrow cells of xid or btk null mice exhibited mild impairments in degranulation, and more profound defects in the production of several cytokines, upon Fc{varepsilon}RI cross-linking. Moreover, the transcriptional activities of these cytokine genes were severely reduced in Fc{varepsilon}RI-stimulated btk mutant mast cells. The specificity of these effects of btk mutations was confirmed by the improvement in the ability of btk mutant mast cells to degranulate and to secrete cytokines after the retroviral transfer of wild-type btk cDNA, but not of vector or kinase-dead btk cDNA. Retroviral transfer of Emt (= Itk/Tsk), Btk's closest relative, also partially improved the ability of btk mutant mast cells to secrete mediators. Taken together, these results demonstrate an important role for Btk in the full expression of Fc{varepsilon}RI signal transduction in mast cells.

Address correspondence to Toshiaki Kawakami, La Jolla Institute for Allergy and Immunology, 10355 Science Center Dr., San Diego, CA 92121. Phone: 619-558-3500; Fax: 619-558-3526; E-mail: toshi_ kawakami{at}liai.org

1Abbreviations used in this paper: BMMC, bone marrow–derived cultured mast cells; Btk, Bruton's tyrosine kinase; ITAM, immunoreceptor tyrosine–based activation motif; NFAT, nuclear factor of activated T cells; PCA, passive cutaneous anaphylactic; PH, pleckstrin homology; PKC, protein kinase C; PLC, phospholipase C; PTK, protein tyrosine kinase; SCF, stem cell factor; SH, Src homology.

This study was partly supported by National Institutes of Health grants RO1 AI-33617 and RO1 AI-38348 (T. Kawakami) and R37 AI-23990 and RO1 CA-72074 (S.J. Galli) and is Publication No. 147 from the La Jolla Institute for Allergy and Immunology.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS